Cargando…

Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. The purpose of this study was to evaluate the clinical features, prognostic factors, and results of DLBCL that was treated in the cancer centers of the public health system in Chile and compare cyclophosphamide, doxorubicin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabrera, María Elena, Peña, Camila, Leon, Pilar, Lois, Vivianne, Rojas, Hernán, Vega, Valeska, Pizarro, Alvaro, Calderon, Susana, Rojas, Christine, Aspillaga, Augusto, Gonzalez, M. Luisa, Intriago, Marvila, Rojas, Bernardita, Hales, Cecilia, Oliva, Jacqueline, Romero, Mónica, Capurro, Marisa, Castillo, Jorge J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166504/ https://www.ncbi.nlm.nih.gov/pubmed/36351213 http://dx.doi.org/10.1200/GO.22.00165

Ejemplares similares

STGC ASSEMBLING AND TESTING IN CHILE FOR THE ATLAS MUON SPECTROMETER
por: Rojas, Rimsky Alejandro
Publicado: (2019)

Considerations and analysis of the implementation of oncogeriatrics in Chile and its importance: Review of current literature
por: Honorato, Macarena, et al.
Publicado: (2023)

High-frequency oscillatory ventilation in adults: experience in Chile
por: Ugarte, SU, et al.
Publicado: (2011)

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
por: Terada, Yoshiki, et al.
Publicado: (2009)

Chile's agricultural research institute plant tissue analysis dataset
por: Corradini, Fabio, et al.
Publicado: (2023)

The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression
por: Wei, Xiaolei, et al.
Publicado: (2014)

Overuse of Health Care in the Emergency Services in Chile
por: Alvial, Ximena, et al.
Publicado: (2021)

Skin cancer risk affected by ultraviolet solar irradiance in Arica, Chile
por: RIVAS, MIGUEL, et al.
Publicado: (2014)

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Li, Xueying, et al.
Publicado: (2019)

Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
por: Hu, Xin, et al.
Publicado: (2017)

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
por: Claustre, Gwladys, et al.
Publicado: (2022)

Evaluation and comparison of the dermatology program for medical students at the University of Chile with other national and foreign universities
por: Rojas, Camilo, et al.
Publicado: (2021)

Genetic analysis of the first mcr-1 positive Escherichia coli isolate collected from an outpatient in Chile
por: Gutiérrez, Camila, et al.
Publicado: (2019)

Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
por: Hong, Junshik, et al.
Publicado: (2010)

First meeting “Cystic echinococcosis in Chile, update in alternatives for control and diagnostics in animals and humans”
por: Alvarez Rojas, Cristian A., et al.
Publicado: (2016)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Poverty determinants of acute respiratory infections among Mapuche indigenous peoples in Chile's Ninth Region of Araucania, using GIS and spatial statistics to identify health disparities
por: Rojas, Flavio
Publicado: (2007)

Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
por: Sekiguchi, Naohiro, et al.
Publicado: (2018)

Perspectives on Inequity and Health Disparities in Chile and Their Relationship to Microbial Ecology
por: Izcue, José, et al.
Publicado: (2022)

Erratum to: First meeting “Cystic echinococcosis in Chile, update in alternatives for control and diagnostics in animals and humans”
por: Rojas, Cristian A. Alvarez, et al.
Publicado: (2016)

Long-term monitoring for conservation: closing the distribution gap of Arctocephalus australis in central Chile
por: Cárcamo, Daniel, et al.
Publicado: (2021)

Living at the Frontiers of Life: Extremophiles in Chile and Their Potential for Bioremediation
por: Orellana, Roberto, et al.
Publicado: (2018)

First description of Echinococcus ortleppi and cystic echinococcosis infection status in Chile
por: Corrêa, Felipe, et al.
Publicado: (2018)

A general modeling framework for quantitative tracking, accurate prediction of ICU, and assessing vaccination for COVID-19 in Chile
por: Cumsille, Patricio, et al.
Publicado: (2023)

Characterization of Communes with Quality Accredited Primary Healthcare Centers in Chile
por: Coss-Mandiola, Juan, et al.
Publicado: (2022)

Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma
por: Kim, Kwang Min, et al.
Publicado: (2008)

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
por: Lisenko, K., et al.
Publicado: (2017)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP
por: Procházka, Vít, et al.
Publicado: (2020)

Virtual reality interface devices in the reorganization of neural networks in the brain of patients with neurological diseases
por: Gatica-Rojas, Valeska, et al.
Publicado: (2014)

Telerehabilitation in Low-Resource Settings to Improve Postural Balance in Older Adults: A Non-Inferiority Randomised Controlled Clinical Trial Protocol
por: Gatica-Rojas, Valeska, et al.
Publicado: (2023)

Dirofilaria immitis in Dog Imported from Venezuela to Chile
por: Alvarez Rojas, Cristian A., et al.
Publicado: (2023)

PB1852: COMPARISON OF CLINICAL CHARACTERISTICS OF ADULT CHILEAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML), ACCORDING TO THEIR HEALTH CARE SYSTEM: ANALYSIS WITHIN THE FRAMEWORK OF THE PTHEMA AML REGISTRY
por: Romero, Monica, et al.
Publicado: (2023)

Chile: Acceptability of a Training Program for Depression Management in Primary Care
por: Marín, Rigoberto, et al.
Publicado: (2016)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Effectiveness of the kiva antibullying program with and without the online game in chile: A three-arm cluster randomised controlled trial
por: Gaete, J., et al.
Publicado: (2021)

Community-Based Rehabilitation (CBR) in primary care centers in Chile
por: Besoain-Saldaña, Álvaro, et al.
Publicado: (2020)

Perception of clinical educational environment by student of physiotherapy based on the Postgraduate Hospital Educational Environment Measurement Questionnaire in Chile
por: Córdova-León, Karen, et al.
Publicado: (2019)

Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
por: Sanhueza, Matías, et al.
Publicado: (2023)

Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
por: Jang, Geundoo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q6abpsplnso0bblbphd25ekmm2